In just over four years, the Weill Cornell Medical Center Clinical and Translational Science Center (CTSC) has established a strong and highly effective clinical and translational science infrastructure spanning six diverse partners, each a center of excellence: Memorial Sloan-Kettering Cancer Center;Hospital for Special Surgery;Hunter College School of Nursing. Hunter College Gene Center-a Research Center for Minority Institutions (RCMI);Cornell University Cooperative Extension;and Cornell University, Ithaca. The mission of the CTSC in continuation is to leverage the resources and expertise of this rich multi-institutional partnership to create new interdisciplinary teams and support cutting-edge research from bench to bedside to community to health care practice. The proposed grant adds a new partner, the Animal Medical Center a few blocks from WCMC, to increase collaboration with Cornell University College of Veterinary Medicine. Jointly, they bring a new dimension to our CTSC research and their expertise in small animals will enhance pre-clinical research in the area of drug discovery and device development. Built on the accomplishments achieved during the initial funding period, the strategic plans for the next five years are geared to rapidly advance translational science discoveries by: 1) Enhancing the Drug Discovery Pipeline;2) Increasing the Breadth of Research Resources;3) Adding New Expertise and Training Programs;and 4) Enhancing Community Engagement and Dissemination. Moving forward, the anticipated benefits of fostering """"""""Innovation through Collaboration"""""""" during the next funding period include: 1) Further generation of novel ideas leading to drug development and medical devices which benefit patient care;2) Increased collaborative efforts with partners and industry, to facilitate research to improve the general health ofthe public;3) Enhanced clinical translational (C/T) educational programs in comparative effectiveness research, global health and health information technology;4) Enhanced community engagement;5) Increased centralization of C/T research, education, infrastructure, and databases;and 6) Enhanced evaluation and tracking of CTSC programs.

Public Health Relevance

The broad research support infrastructure ofthe CTSC and its programs to foster interactions among basic scientists, clinicians and community practitioners are key to the rapid translation of basic science discoveries into effective clinical practice. Our CTSC is distinct in the heterogeneity of its component institutions, providing unparalleled opportunities for collaboration and training in all areas of biomedical sciences. PROJECT/RERFORMANCE SITE(S) (if additional space is needed, use

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR000457-07
Application #
8499477
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Sufian, Meryl
Project Start
2007-09-17
Project End
2017-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
7
Fiscal Year
2013
Total Cost
$8,506,202
Indirect Cost
$1,642,649
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Laird, James; Ma, Jennifer; Chau, Karen et al. (2018) Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement. Int J Radiat Oncol Biol Phys 100:670-678
Erkan, D; Unlu, O; Sciascia, S et al. (2018) Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease. Lupus 27:399-406
Shetty, Teena; Nguyen, Joseph T; Sasaki, Mayu et al. (2018) Risk factors for acute nerve injury after total knee arthroplasty. Muscle Nerve 57:946-950
Zhang, Haiying; Freitas, Daniela; Kim, Han Sang et al. (2018) Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol 20:332-343
Yao, Y; Nguyen, T D; Pandya, S et al. (2018) Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging to Quantify Iron-Related Myelin Damage in Chronic Active MS Lesions. AJNR Am J Neuroradiol 39:303-310
Benedict, Catherine; Thom, Bridgette; Friedman, Danielle N et al. (2018) Fertility information needs and concerns post-treatment contribute to lowered quality of life among young adult female cancer survivors. Support Care Cancer 26:2209-2215
Allan, John N; Roboz, Gail J; Askin, Gulce et al. (2018) CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine. Leuk Lymphoma 59:821-828
Pianko, Matthew J; Goldberg, Aaron D; Lesokhin, Alexander M (2018) Clinical Development of PD-1 Blockade in Hematologic Malignancies. Cancer J 24:31-35
Francis, Jenny K R; Dapena Fraiz, Lauren; de Roche, Ariel M et al. (2018) Management of Adolescent-Parent Dyads' Discordance for Willingness to Participate in a Reproductive Health Clinical Trial. J Empir Res Hum Res Ethics 13:42-49
Eriksson, Anders; Anand, Prachi; Gorson, Juliette et al. (2018) Using Drosophila behavioral assays to characterize terebrid venom-peptide bioactivity. Sci Rep 8:15276

Showing the most recent 10 out of 756 publications